Alterity Therapeutics (ATHE) Short-term Investments (2011 - 2025)

Alterity Therapeutics' Short-term Investments history runs 6 years deep, the most recent figure standing at $26779.7 for Q2 2025.

• In Q2 2025, Short-term Investments changed 0.08% year-over-year to $26779.7; the TTM figure through Jun 2025 stood at $26779.7 (changed 0.08% YoY), while the FY2025 annual figure was $26779.7, changed 0.08% from the prior year.
• Short-term Investments was $26779.7 for Q2 2025 at Alterity Therapeutics, roughly flat from $26801.2 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $26801.2 in Q2 2024 to a low of -$189.88 in Q4 2022.
• Historically, Short-term Investments has averaged $17459.3 across 4 years, with a median of $26576.7 in 2023.
• The sharpest annual moves came in 2023 and 2025: Short-term Investments soared 262.63% in 2023, then slipped 0.08% in 2025.
• A 4-year view of Short-term Investments shows it stood at -$189.88 in 2022, then surged by 14096.62% to $26576.7 in 2023, then grew by 0.84% to $26801.2 in 2024, then decreased by 0.08% to $26779.7 in 2025.
• The last three Short-term Investments figures came in at $26779.7 (Q2 2025), $26801.2 (Q2 2024), and $26576.7 (Q2 2023), per Business Quant data.